Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region
Autor: | Uday Phadke, Duc-Cong Nguyen, Eric S.H. Lau, Banshi Saboo, Lee Ling Lim, Vanessa Lau, Yi-Jen Hung, Aravind Sosale, Parinya Chamnan, Su-Yen Goh, Ronald C.W. Ma, Thi Thanh Huyen Vu, Jothydev Kesavadev, Neeru Gera, Lee-Ming Chuang, Andrea O.Y. Luk, Alexander Tong Boon Tan, Manoj Chawla, Amy W C Fu, Juliana C.N. Chan, Subir Ray, Alice P.S. Kong, Yook Chin Chia, Wayne Huey-Herng Sheu |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
Technology Psychological intervention Blood Pressure Type 2 diabetes law.invention chemistry.chemical_compound Randomized controlled trial law Neoplasms Medicine Diabetic Nephropathies Asia Southeastern Original Investigation Evidence-Based Medicine Disease Management General Medicine Middle Aged Quality Improvement Diabetic Foot Online Only Diabetes and Endocrinology Cardiovascular Diseases Female medicine.medical_specialty Taiwan India Risk Assessment Amputation Surgical Internal medicine Diabetes mellitus Humans Mortality Renal Insufficiency Chronic Developing Countries Aged Glycated Hemoglobin Diabetic Retinopathy Intention-to-treat analysis business.industry Self-Management Research Cardiometabolic Risk Factors Cholesterol LDL Odds ratio Decision Support Systems Clinical medicine.disease Treatment Adherence and Compliance Clinical trial Diabetes Mellitus Type 2 chemistry Glycated hemoglobin Patient Participation business |
Zdroj: | JAMA Network Open |
ISSN: | 2574-3805 |
Popis: | Key Points Question What are the effects of a quality improvement intervention on the care and cardiometabolic risk factors of patients with type 2 diabetes in low- and middle-income countries in the Asia-Pacific region? Findings In this randomized clinical trial of 20 834 patients with type 2 diabetes in 8 Asia-Pacific countries, the intervention group received a technology-guided structured evaluation, automated personalized reports to encourage patient empowerment, and nurse reminders to increase patient engagement over a 12-month period. Clinical events were similar between the control and intervention groups at 12 months; however, the intervention group was more likely to experience reductions in multiple risk factors and increases in the attainment of diabetes-associated targets. Meaning The study’s findings indicate that the use of information and communications technology and nurses to empower and engage patients did not change the number of clinical events but did reduce cardiometabolic risk factors among patients with type 2 diabetes in low- and middle-income countries. Importance Many health care systems lack the efficiency, preparedness, or resources needed to address the increasing number of patients with type 2 diabetes, especially in low- and middle-income countries. Objective To examine the effects of a quality improvement intervention comprising information and communications technology and contact with nonphysician personnel on the care and cardiometabolic risk factors of patients with type 2 diabetes in 8 Asia-Pacific countries. Design, Setting, and Participants This 12-month multinational open-label randomized clinical trial was conducted from June 28, 2012, to April 28, 2016, at 50 primary care or hospital-based diabetes centers in 8 Asia-Pacific countries (India, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam). Six countries were low and middle income, and 2 countries were high income. The study was conducted in 2 phases; phase 1 enrolled 7537 participants, and phase 2 enrolled 13 297 participants. Participants in both phases were randomized on a 1:1 ratio to intervention or control groups. Data were analyzed by intention to treat and per protocol from July 3, 2019, to July 21, 2020. Interventions In both phases, the intervention group received 3 care components: a nurse-led Joint Asia Diabetes Evaluation (JADE) technology-guided structured evaluation, automated personalized reports to encourage patient empowerment, and 2 or more telephone or face-to-face contacts by nurses to increase patient engagement. In phase 1, the control group received the JADE technology–guided structured evaluation and automated personalized reports. In phase 2, the control group received the JADE technology–guided structured evaluation only. Main Outcomes and Measures The primary outcome was the incidence of a composite of diabetes-associated end points, including cardiovascular disease, chronic kidney disease, visual impairment or eye surgery, lower extremity amputation or foot ulcers requiring hospitalization, all-site cancers, and death. The secondary outcomes were the attainment of 2 or more primary diabetes-associated targets (glycated hemoglobin A1c This randomized clinical trial examines the effects of a quality improvement intervention comprising information and communications technology and increased contact with nurses on the clinical care and cardiometabolic risk factors of patients with type 2 diabetes in Asia-Pacific countries. |
Databáze: | OpenAIRE |
Externí odkaz: |